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Protein N-terminal acetylation is a co- and posttranslational modification, conserved among eukaryotes. It determines
the functional fate of many proteins including their stability, complex formation, and subcellular localization. N-terminal
acetyltransferases (NATs) transfer an acetyl group to the N-termini of proteins, and the major NATs in yeast and humans are NatA,
NatB, andNatC. In this study, we characterized theTrypanosoma cruzi (T. cruzi)NatC andNatA protein complexes, each consisting
of one catalytic subunit and predicted auxiliary subunits.The proteins were found to be expressed in the three main life cycle stages
of the parasite, formed stable complexes in vivo, and partially cosedimented with the ribosome in agreement with a cotranslational
function. An in vitro acetylation assay clearly demonstrated that the acetylated substrates of the NatC catalytic subunit from T.
cruzi were similar to those of yeast and human NatC, suggesting evolutionary conservation of function. An RNAi knockdown of
the Trypanosoma brucei (T. brucei) NatC catalytic subunit indicated that reduced NatC-mediated N-terminal acetylation of target
proteins reduces parasite growth.
1. Introduction
Trypanosomes are protozoan parasites that can cause severe
health problems, mainly in developing countries. Try-
panosoma cruzi is the causative agent of Chagas disease,
common throughout Latin America, while T. brucei, mainly
present in Africa, causes sleeping sickness in humans and
Nagana in livestock [1, 2]. There is no vaccine against trypan-
osome-related diseases and the available drugs cause serious
side effects [3, 4].The study about N-terminal acetylation as a
possible chemotherapeutic target to fight parasite infections
is limited. Protein N𝛼-acetylation (Nt-acetylation) is an
irreversible protein modification where the acetyl moiety is
transferred to theN𝛼 amino group of a protein or polypeptide
by N-terminal acetyltransferases (NATs). NATs are grouped
according to their substrate specificity. In humans, seven
NATs have been identified so far (NatA-F and NatH) [5, 6].
Of these, NatA, NatB, and NatC have the largest number
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of substrates and have been characterized extensively. The
human NatA protein complex is composed of a catalytic
subunit (hNaa10) and an auxiliary subunit (hNaa15) and
the human NatC consists of a catalytic (hNaa30) subunit
and two auxiliary (hNaa35 and hNaa38) subunits [7, 8]. The
proteins form stable complexes in vivo and cosediment with
the ribosome [8, 9]. Of late, studies exploring the biological
significance of NATs have become topical, in particular with
regard to how they contribute to cellular integrity and their
roles in cancer [10, 11]. At the substrate protein level, Nt-
acetylation may act as a degradation signal [12], mediate
protein complex formation [13], or inhibit post-translational
ER-translocation [14]. Indeed, both human NatC and NatA
have been suggested as possible target to control cancer [8,
15].
In N-terminal acetyltransferases (NATs), the co- and
posttranslational modification is common in all kingdoms
of life. About 60 %, 90 %, 75 %, and 18 % of yeast, human,
plant, and archaea proteins, respectively, are thought to beNt-
acetylated [5, 16, 17].
The NatA complex from T. brucei has been found to be
essential for cell viability in both the mammalian and insect
stages [18]. We previously characterized a novel acetyltrans-
ferase, the catalytic subunit of the NatC complex in T. cruzi
[19], thought to belong to the NatC subgroup. In the present
study, we have characterized and begun to investigate the
biological significance of the predicted NatC and NatA in T.
cruzi.
We demonstrate that the catalytic subunits (TcNaa10
and TcNaa30), and the predicted auxiliary subunits are
expressed and cosediment with the ribosome. We find that
TcNaa30 catalyzes the acetylation of N-termini similar to
those acetylated by NatC in yeast (yNaa30) and hNaa30 in
vitro and our analyses indicate that the protein may function
both as a N𝛼- and as a N𝜀-acetyltransferase. Finally, there
is an indication that the knockdown of the T. brucei NatC
catalytic subunit is important to the parasite.
2. Materials and Methods
2.1. Cell Culture. T. cruzi CL Brener epimastigotes were
cultured as previously described [19]. Tissue culture derived
trypomastigotes were obtained through infection of a Vero
cell monolayer, harvesting the media by centrifugation at
1640 g for 10 min. Amastigotes were obtained by harvesting
5 x 106 trypomastigotes per ml and incubating in serum-free
DMEM for 48 h at 37∘C. Metacyclogenesis was induced by
separating 5 x 106 epimastigotes per ml into Grace’s insect
medium supplemented by intestinal homogenate from Rhod-
nius prolixus [20] and 0.5 % pyruvate-glutamate-antibiotic
(PGAB). T. brucei strains were grown in HM-I9 medium at
37∘C, 5 % CO
2
.
2.2. Identification, Cloning, and Expression of Suspected
TcNatC and TcNatA Subunits. HumanMak3 (hNaa30), gene
ID 122830, and hNaa38 (NP 001317040.1 GI:1052793474)
sequences were BLASTed against the T. cruzi CL Brener pro-
teome in order to identify T. cruzi homologs of NatC catalytic
and an auxiliary subunit. Similarly, the second TcNatC aux-
iliary subunit was identified using plant Mak10 acetyltrans-
ferase Arabidopsis thaliana NP 001118295.1, GI:186500070 or
Rattus norvegicus NP 579858.1 GI:19033372. The auxiliary
subunits were amplified from total genomicDNA from Sylvio
strain (TcI) using the following primers TcNATC mak10
Forward: 5󸀠 CGAATTCATGGCGTGTGACCTTGA 3󸀠, and
TcNATC mak10 Reverse: 5󸀠 GAGCGGCCGCTTACCT-
GGCTTCCTTCTTG 3󸀠, with EcoR1 and Not1 restriction
sites (underlined), respectively, and, TcLsmd1 Forward: 5󸀠
GGAATTCATGGGCCGCGAGAGCATGCTTCACAA 3󸀠
and TcLsmd1 Reverse: 5󸀠 AAGCTCGAGTTAGCGCTT-
CCGCTT 3󸀠, with EcoR1 and XhoI restriction sites (under-
lined).The genes were cloned into pGEX5-1 vector expressing
GST (glutathione S-transferase) and recombinant proteins
were produced. The pelleted bacteria was dissolved in PBS
containing EDTA-free protease inhibitor tablets (Roche), 1
mM EDTA, and 100 𝜇g lysozyme and incubated on ice for
about 15 min. Sarkosyl was added to a concentration of 1.5 %.
The cells were briefly sonicated four times, 10 s each, with 30
s pauses using Branson sonifier cell disruptor B 15.The pellet
and supernatant were analyzed to detect the presence of the
induced protein.
For the TcNatA subunits, human or yeast NatA sequences
were used as queries in the NCBI BLAST database in
order to identify TcNatA homologues. T. cruzi gene
TcCLB.506227.230 (predicted catalytic subunit, which we
named TcNaa10) and gene TcCLB.510301.80 (predicted auxil-
iary subunit, named TcNaa15) were identified.The genes were
amplified from genomic DNA using the following primers:
TcNAA10 Forward: 5󸀠 AAGAATTCATGCAGATCCGT-
CGC 3󸀠, TcNAA10 Reverse: 5󸀠AAACTCGAGCTTTTTCGT-
CTTGCC 3󸀠, TcNAA15 Forward: 5󸀠 ATCGGAATTCCGG-
TAGTGCTTCCTCCGGCG 3󸀠, and TcNAA15 Reverse: 5󸀠
ATCGCTCGAGGCGCTGGCCAACACCTCATCA 3󸀠.
Bold and underlined are EcoRI (forward) and XhoI (reverse)
restriction sites.
The genes were subsequently cloned into the pGEX5-
1 vector expressing GST (glutathione S-transferase) yield-
ing pGEX5-1-TcNaa10 and pGEX5-1-TcNaa15. The reading
frames were confirmed as described previously [19]. Bacterial
Top10 cells (Invitrogen) transformed with pGEX5-1-TcNaa10
were grown at 37∘C until approximately OD
600
0.5 and
induced with 0.3 mM isopropyl𝛽-D-1-thiogalactopyranoside
(IPTG). Cells were grown and processed as described
before [19], except that protease inhibitor (EDTA-free tablet
inhibitor from Roche) was used. The bacterial Top10 cells
(Invitrogen) transformed with pGEX5-1-TcNaa15 were grown
to approximately OD
600
0.8 and induced with 0.1 mM IPTG
at 24∘C for about 24 h and further processed as was done for
pGEX5-1-TcNaa10.
2.3. Generation of Anti-TcNaa10, TcNaa15, and Anti-TcNaa38
Antibodies and Western Blot Analysis. The antibody produc-
tion for TcNaa10 and TcNaa38 was performed in a rabbit by
Innovagen (Lund, Sweden), as before [19]. ProteinGwas used
to purify the IgGs. The anti-GST antibodies were removed
by passing the immunoglobulin through a GST-column. The
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depletion and titer were evaluated by immunoblotting toGST
andGST-TcNaa38 andGST-TcNaa10 electrotransferred strips
(not shown). Antibody against TcNaa15 was generated by
the Agrisera company (Umeå-Sweden) by inoculating one
rabbit with synthetic peptides: Naa15-EL (700-712) (NH2-)
CDEVLASAWEKIKE (-COO). The peptide sequence was
selected from conserved regions from both CL Brener haplo-
types (non-Esmeraldo and Esmeraldo like). Western blotting
was performed using standard procedures and as before [19].
The anti-TcNaa10, anti-TcNaa15, and anti-TcNaa38 antibodies
were used at a dilution of 1:4000, 1:2000, and 1:2000, respec-
tively. For comparison between life cycle stages, fractions
containing 106 cells were lysed directly in sample loading
buffer and separated on a 15 % acrylamide gel. Proteins
were transferred using a semidry system and the membrane
probed with, for example, anti-TcNaa38 overnight.
2.4. In Vitro Acetylation Assay. E. coli cells harboring the
expression plasmid pGEX5-TcNaa30 were grown at 37∘C
in Luria-Bertani medium containing appropriate amounts
of ampicillin. Expression was induced at approximately 0.5
OD600 by the addition of 0.3 mM IPTG and growth was
continued for additional 18 h at 17∘C, 190 rpm.The cells were
processed as described previously [19].
The enzyme activity of purified GST-TcNaa30 was deter-
mined as described in [8]. In brief, GST-TcNaa30 was mixed
with potential oligopeptide substrates (300 mM) and acetyl-
CoA (300 mM) in a total volume of 60 𝜇l acetylation buffers.
The samples were incubated at 37∘C for 30 min. The enzyme
activitywas quenched by adding 5𝜇l of 10%TFA.Theamount
of acetylated oligopeptides was determined based on the
absorbance at 215 nm after analysis with RP-HPLC. Synthetic
Peptide Sequences used were as described elsewhere [7, 8].
To assess the TcNaa10 acetyltransferase activity, recombi-
nant protein was expressed as described above, except that
growth was continued for another 25 h at 17∘C, 189 rpm.The
cells were chilled on ice and harvested by centrifugation at
5000 rpm for 15 min. The cell pellet was suspended in 5 ml of
ice-cold PBS containing EDTA-free tablets inhibitor (Roche).
Cells were sonicated 4 times, 10 s each using a Branson
sonifier cell disruptor B 15. Five ml of cold PBS + inhibitor,
0.5 ml of 20 % Triton X-100 (final conc. 1 %) was added and
the cells were incubated for 30 min at 4∘C and thereafter
centrifuged for 15 min at 10,000 rpm. From a 50 % slurry of
glutathione-Sepharose 4B (GE Healthcare), about 250 𝜇l was
added to the supernatant and the mixture was incubated for
2-3 h at 4∘C. The beads were washed three times with cold
PBS containing 1 % Triton X-100, followed by one wash with
PBS.The amount of protein on the beads was estimated from
Coomassie staining of SDS-PAGE gels.
The purified recombinant protein (GST-TcNaa10), eluted
from the beads, was incubated with acetyl-CoA and synthetic
peptides suggested to be the substrates for NatA. The activity
of the enzyme was stopped after 30 min and the results
analyzed by HPLC.
2.5. ImmunofluorescenceMicroscopy. Parasiteswere prepared
for IF essentially as previously described [21], fixing in 4
% paraformaldehyde for 5 min. Cells were then blocked in
10 % goat serum and primary antibodies were used at a
1:50 dilution for 1 h. Anti-rabbit AlexaFluor488 was used
to recognize the primary antibodies and cells were DAPI
stained prior to mounting in Fluoromount. Imaging was
achieved using a Zeiss Axioplan2 microscope and Axiovision
4.7 software.
2.6. Immunoprecipitation (IP). Approximately 109 parasites
per ml were used for immunoprecipitation. Exponentially
growing cells were lysed in lysis buffer [0.75 % CHAPS
detergent, 1 mM MgCl2, 1 mM EGTA, 5 mM 𝛽- mercap-
toethanol, 10mMTris-HCL (pH7.6), 10% glycerol, and 1mM
Pefabloc (Roche)].The sample was incubated on ice and later
centrifuged. The supernatant was precleared by incubation
with protein A/G–agarose (Santa Cruz Biotechnology) on a
roller for 1 h at 4∘C.Thebeadswere removed by centrifugation
at 1000 g for 3 min. The cell lysate was incubated with
about 2 𝜇g of anti-TcNaa10 or anti-TcNaa30 antibody. As
a control, one part of the lysate was incubated with rabbit
sera (preimmune). Both samples were incubated on a roller
for about 2.5 h at 4∘C before adding 30 𝜇l of Protein
A/G–agarose beads and further incubated overnight at the
same temperature.Thebeadswere collected by centrifugation
as above, washed, mixed with sample buffer, and boiled for
10 min. After centrifugation, the supernatant was analyzed
by SDS/PAGE and western blotting. Reciprocal IP with anti-
TcNaa15 or anti-TcNaa38 was done as described except that,
in this case, the lysate was not precleared.
2.7. Polysome Isolation. Total ribosome isolation was per-
formed using amodification of previously describedmethods
[8]. Approximately 109 cells were used per experiment.
Prior to harvesting, parasites were treated with 100 𝜇g/ml
cycloheximide (CHX) for about 10min on ice. Cellswere then
lysed with KCl ribosome lysis buffer [8] and incubated on
ice for 15 min. Cells were homogenized by repeated pipetting
and the homogenate verifiedwith lightmicroscopy.The lysate
was centrifuged at 18000 g at 4∘C for 5 min using Beckman
rotor 25.50. One ml of the lysate was overlaid on 3 ml of 25
% sucrose cushion sucrose and ultracentrifuged at 135,715.5
g for 2 h using Sorvall AH-650 rotor (Beckman). The pellet
was dissolved in ribosomal lysis buffer. Total parasite lysate,
top supernatant (post-polysome lysate), and ribosomal pellet
were analyzed by SDS-PAGE and western blotting.
2.8. Nuclear and Cytoplasmic Preparation. About 107 expo-
nentially growing parasites were washed twice in PBS and
lysed in 10 ul of TELT buffer (50 M Tris-HCL pH 8, 62.5
mM EDTA, 2.5 M LiCl, 0.4 % Triton X-100, and 100 mg/ml
lysozyme). Thereafter, NE-PER Nuclear and Cytoplasmic
Extraction Reagents kit from Thermo Scientific was used
according to recommendation, but with double amount of
reagents. Prior to the use of the kit, the parasites were
lysed by TELT, as the detergent provided with the kit
did not lyse the parasite at the condition tested. Anticy-
clophilin A (kindly provided by Jacqueline Búa, Instituto
Nacionale de Parasitologia, Buenos Aires, Argentina) and
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Table 1: TcNatC and TcNatA genes. ∗ denotes genes investigated in this study.
TcNat Gene CL Brener haplotype
TcNatC catalytic subunit (TcNaa30) Tc00.1047053511809.120 (Tc9.120) Non- Esmeraldo-like ∗
Tc00.1047053511811.30 (Tc1.30) Esmeraldo- like
TcNatC auxiliary subunit (TcNaa35) Tc00.1047053511311.80 (Tc1.80) Esmeraldo- like
Tc00.1047053511755.119 (Tc5.119) Non- Esmeraldo-like ∗
TcNatC auxiliary subunit (TcNaa38) Tc00.1047053507209.10 (Tc9.10) Non- Esmeraldo-like ∗
TCNatA catalytic subunit (TcNaa10) TcCLB.506227.230 (Tc7.230) Esmeraldo-like ∗
TCNatA auxiliary subunit
(TcNaa15) TcCLB.504163.110 (Tc3.110) Esmeraldo-like
TcCLB.510301.80 (Tc01.80) Non-Esmeraldo-like ∗
antihistone 3 from Upstate (Millipore) were used as pos-
itive control for cytoplasmic and nuclear proteins, respec-
tively.
2.9. Bioinformatics. Homology searches were performed
using the NCBI BLAST server. Extracted protein sequences
were aligned using Clustal Omega multiple sequence align-
ment tool. ScanProsite and InterPro Protein sequence
analysis and classification tools were used to identify
domains.
2.10. Generation of Predicted T. brucei NatC Catalytic Sub-
unit (TbNaa30) RNAi Cell Lines. The putative protein-
coding region comprising nucleotides (216-788) of the pre-
dicted TbNaa30 (Tb927.7.2360), that is, a 573 bp frag-
ment, was PCR-amplified using forward primer TbNatC-
Naa30RNAi: 5󸀠 ATCGGGATCCCTACGGATGTCGCTC-
CTAGC 3󸀠 and reverse primer TbNatC- Naa30RNAi:
5󸀠 ATCGAAGCTTGTAGCGCGGCAGAAATTTAG 3󸀠.
Underlined are BamHI and Hind III restriction sites, respec-
tively. The PCR product was subcloned into tetracycline-
inducible RNAi vector p2T7-177 using the restriction sites
to yield p2T7-TbNaa30. The presence of the insert was ver-
ified by digesting the plasmid with respective enzymes. For
easy incorporation into the chromosome, resulting plasmid
(about 10 𝜇g) was linearized with NotI and transfected
into T. brucei brucei 427 strain by electroporation, using
about 2 x 107 cells. Nonlinearized plasmid and mock trans-
fection were used as negative controls. The transformants
were selected with phleomycin (2.5 𝜇g). To confirm if the
transfection was successful, DNA was extracted from the
surviving parasites and PCR was performed to amplify
the phleomycin gene fragment (350 bp) using specific
primers (Phleo Forward 5󸀠 ATG GCC AAG TTG ACC
AGT GCC 3󸀠 and Phleo Reverse 5󸀠 TGC ACG CAG TTG
CCG GCC GGG 3󸀠). The starting parasite density of 2.5
x 104 /ml was used and RNAi was induced using 100 ng
of tetracycline. The same parasite density was used for
the transformants and wild type (T. b. brucei 427). The
noninduced/wild type and induced cells were examined
and counted daily using light microscopy. Samples for
gene/protein expression analyses were harvested daily for five
days.
3. Results
3.1. Identification and Sequence Analysis of TcNat Proteins.
The catalytic subunit of the TcNatC complex was identified
by blast analysis and as previously described [19] (Table 1).
In accordance with the recommended nomenclature [22],
we now refer to this gene as TcNaa30. Similarly, we iden-
tified putative genes for the T. cruzi homologues of NatC
auxiliary subunits (TcNaa35 and TcNaa38) (Table 1). The
gene showed 19 %, 22 %, 49 %, and 62 % sequence
identity at the aa level to its rat, plant, Leishmania major,
and T. brucei counterpart, respectively. For TcNaa38, gene
Tc00.1047053507209.10 (Tc9.10) was identified as the likely
TcNatC subunit (Table 1). At the aa level, the TcNaa38 gene
shares 32 %, 38 %, 57 %, and 62 % sequence identity with its
yeast, human, Leishmania major, and T. brucei counterpart,
respectively.
T. cruzi NatA homologs were identified by comparing
with human Naa10 (gene ID 728880) (Table 1). The T. cruzi
gene TcCLB.506227.230 (Tc7.230) was found to share 60 %
and 42 % identity at the amino acid (aa) level with the
human and yeast genes, respectively. We now refer to this
gene as TcNaa10 according to the latest nomenclature [22].
In a search to identify the T. cruzi NatA auxiliary subunit,
we used hNaa15 (NP 476516.1), as a BLAST query sequence.
As seen in Table 1, the search identified CL Brener gene
TcCLB.504163.110 (Tc3.110) and TcCLB.510301.80 (Tc01.80),
with 29 % and 28 % sequence identity at the aa level,
respectively. Both alleles were annotated as putative N-
acetyltransferase subunit Nat1 and named TcNaa15. Sequence
comparison of predicted TcNaa35, TcNaa38, TcNaa10, and
TcNaa15 with selected species is displayed in (Supplementary
Figure S1).
3.2. Expression and Recombinant Production of TcNatA and
TcNatC Protein Subunits. We previously expressed the puta-
tive TcNaa30 and showed that it has autoacetylation enzyme
activity [19]. To further characterize the TcNatC and TcNatA
protein complex, we cloned the TcNaa35 and TcNaa38 ORFs
and produced recombinant protein (Supplementary Figures
S2A and S2B show the recombinant protein (GST-TcNaa35
and GST-TcNaa38) with an expected size of about 110 and
40 kDa, respectively). The annotated proteins of TcNaa10
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Figure 1: Expression of TcNaa38/TcNaa30 and TcNaa10/TcNaa15 in trypanosomes. (a) Total proteins from different stages of T. cruzi life
cycle, epimastigote midlog (M), epimastigote stationary phase (S), trypomastigote (T), and amastigote (A) were used for western blotting.
(b) Cross reaction of anti-TcNaa30 and anti-TcNaa38 against different T. brucei strains. Tb-Gvr (T. brucei GVR strain), Tb-R17 (T. brucei R17
strain), and Tc-Brener epimastigote (T. cruzi CL Brener strain). (c) Developmental stage expression of TcNaa10 and TcNaa15 in CL Brener
strain epimastigote (E), trypomastigote (T), and amastigote (A). Purified anti-TcNaa10 and anti-TcNaa15 (1:4000, and 1: 2000 dilutions) were
used for western blotting. (d) Cross reaction of anti-TcNaa10 (upper panel) and anti- TcNaa15 (lower panel) against different T. brucei strains.
The T. brucei strains used were GVR35 (Gvr), R17 and UTRO 091B (Utr).
and TcNaa15 have predicted molecular weights of 29.4 and
82.9 kDa, respectively, and we again produced recombinant
proteins. TcNaa10 was initially insoluble (Supplementary
Figures S2C and S2D) and was dissolved in sarkosyl as
described previously [23].
3.3. Expression of TcNaa38/TcNaa30 and TcNaa10/TcNaa15
in the Parasite. To investigate the expression pattern of
TcNatC and TcNatA, we used western blot to detect the
proteins in the different stages of the parasite life cycle. In
the study, polyclonal antibodies were produced in rabbit
against the whole protein. The antibody against TcNaa15 was
generated in a rabbit using synthetic peptides. For all the
proteins assessed, we first carried out western blot analysis
for preimmune rabbit sera, and, as expected, no band/signal
was detected (not shown).
Analysis showed that TcNaa38 was expressed in the
three main stages, i.e., in the epimastigote, trypomastigote,
and amastigote stages of T. cruzi CL Brener (Figure 1(a)).
However, multiple bands of similar size were recognized in
all the stages, possibly due to posttranslational processing
of proteins. The identity of the extra bands has not been
investigated in this study. Anti-TcNaa38 and anti-TcNaa30
also recognized, for example, GVR35 [24] and UTRO [25]
strains of T. brucei proteins (Figure 1(b)). TcNaa10/TcNaa15
were also found to be expressed in epimastigote, trypomastig-
ote, and amastigote stages of the T. cruzi CL Brener strain
(Figure 1(c)). Anti-TcNaa15 detected additional bands in all
developmental stages, except amastigotes. The identities of
these bands are not known. Furthermore, the result sug-
gests an upregulation of TcNaa15 in the trypomastigote and
amastigote stages with an opposite effect seen for TcNaa10,
that is, downregulated in trypomastigotes and amastigotes
(Figure 1(c)). As displayed in (Figure 1(d)), anti-TcNaa10 was
found to cross react with T. brucei, while anti-TcNaa15,
as expected, did not. In contrast to T. cruzi, anti-TcNaa10
recognized an extra band of 17 kDa in T. brucei, with no
known identity. Taken together, the results indicate that the
TcNatA and TcNatC protein complexes are constitutively
expressed in T. cruzi.
3.4. Localization of TcNaa30 and TcNaa10/TcNaa15 by Frac-
tionation. As shown in [19], the staining profile of the
putative TcNaa30 was predominantly located in the cyto-
plasm, and we now observed the same result by fractiona-
tion (Figure 2(a)). For TcNaa15 and TcNaa10, both proteins
showed nuclear and cytoplasmic location (Figure 2(b)).
3.5. Subcellular Localization of TcNaa30/TcNaa38 and
TcNaa10/TcNaa15 by Immunofluorescence. In assessing
the staining patterns of the four proteins, no staining was
observed by preimmune sera or by secondary antibody
alone (data not shown). In both midlog and stationary
epimastigotes, the TcNaa30 exhibited some perinuclear
accumulation and punctate structures, particularly in the
stationary phase (Figure 3(a)). In both metacyclic and tissue
culture derived trypomastigotes, TcNaa30 appeared to be
relatively sequestered in a perinuclear distribution, as was
observed in [26]. When trypomastigotes were differentiated
into amastigotes in vitro, however, more peripheral staining
was observed (Figure 3(a)). These differences could possibly
be related to differential regulation of protein trafficking.


















Figure 2: Localisation of TcNaa30 and TcNaa10/TcNaa15 in T. cruzi. (a) TcNaa30 localization in epimastigotes by western blotting. (b)
Localization of TcNaa10/TcNaa15. Cytoplasmic (Cyt) and nuclear (N) fractions were assessed for the presence of TcNaa30, TcNaa10, and
















Figure 3: Localization of TcNaa30 andTcNaa10 by immunolabelling. Numbers 1 to 5 denotesmidlog epimastigotes, Stationary epimastigotes,
metacyclic trypomastigotes, Trypomastigotes, and amastigotes, respectively. T. cruzi four life cycle stages were immunolabelled with (a) anti-
TcNaa30 and (b) anti-TcNaa10.The nucleus and kinetoplast were visualized using DAPI stain (N+K), scale bars = 5𝜇m.
TcNaa38 staining was predominantly punctate and cyto-
plasmic labeling more diffuse at the midlog stages (Supple-
mentary Figure S3A). Tissue culture derived trypomastigotes
showed a diffuse cytoplasmic localization with some perinu-
clear accumulation. In amastigotes in vitro, TcNaa38 staining
was again punctate and cytoplasmic (Supplementary Figure
S3A). Using a Vero cell monolayer to assess intracellular
amastigotes, the staining profile showed a diffuse localization
of TcNaa30 in the cytoplasm, and amore punctuated labeling
for TcNaa38 (Supplementary Figure S4).






















Figure 4: Association of TcNaa30/TcNaa38 and TcNaa10/TcNaa15 with the ribosome. (a) Membrane was incubated with anti-TcNaa30 and
anti-TcNaa38. Total cell lysate (T/L), supernatant postultracentrifugation (P/L) and polysomes (Poly) were loaded. As controls, anti-T. cruzi
S7 (specific for the ribosome) and anti-T. cruzi cyclophilin A (nonribosomal) were used. Molecular size markers in kDa are indicated on the
left. (b) Membrane was incubated with anti-TcNaa10 and TcNaa15. Loading control as mentioned in Figure 4(a).
The localization pattern of TcNaa10 and TcNaa15 in
vivo in the four developmental stages of the parasite was
assessed. TcNaa10 was mainly seen around the nucleus in
midlog and stationary epimastigotes (Figure 3(b)). In trypo-
mastigotes, TcNaa10 appeared exclusively around the nucleus
(Figure 3(b)). The staining profile of TcNaa10 in amastig-
otes, meanwhile, was restricted to the periphery of the cell
(Figure 3(b)). In all the life cycle stages, TcNaa15 appeared to
predominantly localize to the cell periphery (Supplementary
Figure S3B). The cytoplasmic labeling disappeared in the
metacyclic stages as TcNaa15 localized to the kinetoplast
(Supplementary Figure S3B). Tissue culture trypomastigotes
exhibited amore diffuse cytoplasmic localization and expres-
sion was reduced to a structure resembling the remaining
short flagellum in amastigotes (Supplementary Figure S3B).
3.6. TcNaa30/TcNaa38 and TcNaa10/TcNaa15 Co-Sediment
with the Ribosome. We examined the TcNaC cosedimen-
tation with the ribosome through a sucrose cushion, and,
as shown in (Figure 4(a)), TcNaa30 is present in both the
ribosomal and nonribosomal fractions. A smaller amount of
TcNaa38 could also be observed in the polysome fraction.
The results for TcNatA (Figure 4(b)) showed the presence of
TcNaa10 and TcNaa15 in both the ribosomal and nonriboso-
mal fractions. Anti-TcNaa15 detected an additional band of
approximately 54 kDa in the ribosomal fraction. In contrast,
anti-TcNaa10 detected a band of about the same size in
the nonpolysome fraction. The identity of the extra band is
not known. Taken together, the ribosomal cosedimentation
results indicated that the TcNatA and TcNatC proteins might
associate with the ribosomes.
3.7. T. cruzi NatC and TcNatA Subunits Interact In Vivo and In
Vitro. Human orthologs of TcNaa30, TcNaa35, and TcNaa38
form a stable complex in vivo [8]. To investigate whether
TcNaa30 and TcNaa38 formed a stable complex in T. cruzi,
immunoprecipitation using anti-TcNaa30 and anti-TcNaa38
was performed. Immunoprecipitation with anti-TcNaa30
was unsuccessful, but using anti-TcNaa38 we were able to
immunoprecipitate TcNaa30 (Figure 5(a)). Though further
study is required, this indicates that these proteins physically
interact inT. cruzi, either directly or through another protein,
for example, the ribosome complex. Likewise, immunopre-
cipitation showed that anti-TcNaa10 was able to immuno-
precipitate TcNaa15 (Figure 5(b)) upper panel. By reciprocal
immunoprecipitation, anti-TcNaa15 was able to pull down
TcNaa10 (Figure 5(b)), lower panel. This analysis suggests
that the TcNaa10 and TcNaa15 interact in vivo in the same
way as yeast and human orthologs of the TcNaa10 and
TcNaa15 form a stable complex in vitro and in vivo [7, 9,
27].
3.8. In Vitro N𝛼-Acetyltransferase Assay. In order to inves-
tigate the substrate specificity of TcNatC and TcNatA, we
performed an in vitro Nt-acetylation assay where purified
recombinant protein (GST-TcNaa30) was incubated with
synthetic peptides representing substrates for different classes
of NATs (NatA-NatE). As shown in (Figure 6), TcNaa30
preferentially acetylates a peptide with a hydrophobic N-
terminal sequence of MLGP, which corresponds to a typ-
ical NatC/E/F substrate in humans. We also attempted to
assess TcNaa10 enzymatic activity and whether the TcNaa10
substrate preferences are identical to those in human cells
in a similar way as above. Though there was an indication
of Naa10 activity, preferentially acetylating the synthetic
peptide sequences STPD and EEEIA (not shown), represent-
ing human NatA substrates, no reproducible activity was
found.
3.9. Effect of Knock down of Predicted T. brucei NatC Cat-
alytic Subunit by RNAi. RNAi was carried out on the T.
brucei equivalent of the TcNaa30 gene. RNAi was induced
in Trypanosoma brucei brucei 427 using tetracycline. For
the wild type, tetracycline had no effect on their viability
(Supplementary Figure S5A).
We observed a reduction in parasite growth in both the
induced and noninduced after 48 h and 72 h (Supplementary
Figures S5B and S5C). This most likely indicated that the
RNAi vector was leaky, or the more unlikely possibility
that the vector itself causes the effect. An RT-PCR assay
(Supplementary Figure S5D) indicated that at 48 h after
induction, there was a decrease in the levels of endogenous












Figure 5: TcNatC and TcNatA protein interaction. (a) Immunoprecipitation (IP) of TcNaa30. The parasite lysate was incubated with anti-
TcNaa38. As a control, the lysate was incubated with rabbit sera (preimmune). The blot was analyzed with anti-TcNaa30. Molecular weight
marker in kDa is indicated. (b) Coimmunoprecipitation assays of TcNaa10 with TcNaa15 protein. IP with preimmune sera was used as a


































Figure 6: In vitro acetyltransferase activity of TcNaa30. GST-
TcNaa30 was incubated with acetyl-CoA (300 mM) and selected
oligopeptides (300 mM) for 30 min at 37∘C. dH2O was used as
negative control. The amount of acetylated peptide was determined
with reverse phaseHPLC. Oligopeptide names indicate the first four
amino acids from the N-terminus. ND represents nondetectable. ∗
indicates that NatA can also posttranslationally acetylate acidic N
termini, for example, 𝛾 actin.
mRNA in the induced and noninduced transformant cell
compared to the wild type. Western blotting using anti-T.
cruziNatC (TcNaa30) showed that, especially after 48 h, there
was lower protein expression in the noninduced and induced
cells compared to the wild type (Figure 7).
4. Discussion
We here describe the molecular cloning and characteri-
zation of the predicted T. cruzi NatC and T. cruzi NatA
N𝛼-acetyltransferase protein complexes. We found that pro-
tein Nt-acetylation by T. cruzi NatC and NatA was sim-
ilar to what has been described in other eukaryotes. It
appears that the expression profile of TcNatA and TcNatC
in different parasite life cycle is not uniform. But, how this
translates to the distinct parasite morphologies and biology
is not clear. Similar to expression, the localization profile
of TcNatC and TcNatA proteins by immunofluorescence
in the different life cycle forms are diverged. The func-
tional significance of these is speculated. Similar staining
patterns were observed [16, 28, 29] for human Naa40/NatD
and other NATs proteins. Given the divergent expression
and localization of the TcNatC and TcNatA proteins, it is
tempting to speculate that, the given protein is located at a
particular compartment at a given time to carry biological
tasks. Considering localization of T. brucei (Tb927.7.2360),
a similar gene to TcNaa30 by GFP-tagged version [30],
the T. brucei gene N-terminally and C-terminally tagged
versions are distributed throughout the cell. Localization
of TcNaa30 in our hands is predominantly distributed in
the cytoplasm, suggesting differential biological function in
trypanosomes. Further analyses are needed to confirm this
hypothesis.
TcNatC andTcNatAproteins physically interactwith each
other and it is plausible that this interaction takes place in the
cytoplasm as suggested by their possible ribosomal cosedi-
mentation. Possibly, the proteins in some cases carry out their
function independently of each other as suggested in other
organisms [16] and that they may have specific functions
depending on the parasite life cycle stage. TcNatC/TcNatA
proteins may also have other functions independent of the
NAT-activity as suggested in other species [15].
The biological significance of posttranslational modifi-
cation of proteins, especially acetylation, in trypanosomes
is relatively unexplored [31]. We predicted the TcNatC sub-
strates profile and detected many parasite-specific proteins
that lack homologues in humans (Table 2). For TcNatA
substrates, the predictions include hypothetical proteins, as
well as mucin-associated surface protein (MASP) and mucin
proteins (not shown). The MASP gene family is prefer-
entially expressed in the trypomastigote [32]. Moreover, it
is exposed to the host immune system and possibly used
by the parasite during infection [32]. Another noticeable
predictedT. cruziNatC andTcNatA substrate is transsialidase
(TS), a polymorphic surface enzyme used by the parasite
during infection [33]. Taken together, it can be speculated
that Nt-acetylation, if lost, could simultaneously affect many
surface antigens including TS, or many parasite-specific
functions and cellular processes that are important for pathol-
ogy.
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Figure 7: Phenotype of the knock-down of putative T. brucei Naa30 by RNAi. TcNaa30 protein expression analysis of wild type (W),
transformant (T), noninduced (-), and induced (+) cells by western blotting. Cells were counted, washed, and dissolved in sample buffer
and immediately boiled. About equal amount of each sample was used in the experiment. Note that a band of about 17 kDa, whose identity
is not known, was also identified. GAPDH was used as loading control.
Table 2: Some estimated number of predictedTcNaa30 substrates for CLBrener haplotypes based onMet-Leu,Met-Ile,Met-Phe, andMet-Tyr
N-termini.
Non-Esmeraldo Esmeraldo
Total genes 1461 1328
hypothetical 830 774
transsialidase 248 203
mucin TcMUCII 2 2
MASP 4 3
For the extracellular parasite T. brucei, some proteins
used by the parasite to evade the host immune system were
predicted as possible substrates for TbNatC (not shown).
These include receptor-like adenylate cyclases [34], variant
surface glycoprotein, and an expression site- associated gene
[35]. Study of the N-terminal acetylome by proteomic meth-
ods in trypanosomes [31] confirms our prediction that Nt-
acetylation state in these organisms is common. Further
studies are required for a complete understanding of which
cellular machineries are regulated this way and how this is
important for the life of the parasite.
In yeast, human, and plants, the biological significance
of NatC knockdown has been investigated [8, 36, 37]. These
studies point towards loss of cell viability if NatC is depleted.
The NatA protein complex was found to be essential for cell
survival in T. brucei [18]. Given the sequence identity and the
similar predicted ligand binding and active sites, it is likely
that NatA is essential in all trypanosomatids. In this study,
silencing of the T. brucei NatC predicted catalytic subunit
by RNAi suggests that the protein may be important to the
parasite, though there was minor reduction of the predicted
protein band in the blot in the transfected cells compared
with the control. Another system for conditional knockouts
for trypanosomatids such as CRISPR/Cas9 could be tested to
ascertain our observation in this study or perform genome-
scale RNAi [38] by silencing the parasites NATs catalytic
subunits and phenotypes assessed. It is clear though that these
are basic, important functions that are of interest for gene
function and regulation as well as for possible drug target
testing.
Collectively, identification of all the NATs in T. cruzi,
analyzing substrates preferences, and proteomic study of Nt-
acetylation in all the developmental stages will narrow the
gaps in knowledge of the parasite biology.
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Supplementary Materials
Supplementary Figure 1: alignment of TcNaa35/TcNaa38
and TcNaa10/TcNaa15 with orthologous sequences from
other eukaryotes. A: comparison of predicted TcNaa35
with other proteins. The tick line indicates predicted
Mak10 domain region. The most conserved aa are
represented by a star (∗). Note that only part of the
alignment is displayed. Polypeptides used are Leishmania
major (XP 001682355.1), T. cruzi (XP 814406.1), T.
brucei (XP 844906.1), Plant (NP 001118295.1), human (SP
|Q5VZE5), and Yeast (NP 579858.1). B: TcNaa38 sequence
alignment with selected proteins. ∗ denotes the most
conserved aa. Sequences included in the alignment are yeast
(NP 010946.3), human (NP 001317040.1), Leishmania major
(XP 003722006.1), T. cruzi (XP-808107.1), and T. brucei
(XP 951644.1). C: comparison of TcNaa10 sequence with
selected eukaryotes. The overlined indicates the consensus
sequence RXXGXA for NatA, where acetyl–CoA binds.
The two arrows indicate the active sites and a symbol ♯
is the predicated possible lysine autoacetylation site. Used
sequences in the alignment are yeast (NP 011877.1), human
(NP 003482.1), Leishmania major (XP 001681770.1), T.
cruzi (XP 817467.1), and T. brucei (XP 828529.1). D:
TcNaa15 sequence comparison with putative homologues
from other species. Polypeptides used in the alignment are
Leishmaniamajor (XP 001686706.1), T. cruzi (XP 807954.1),
T. brucei (XP 822811.1), human (NP 476516.1), and yeast
(END60314.1). ∗ indicates residues, which are highly
conserved. Supplementary Figure 2: recombinant protein
production and analysis on 10 % SDS-PAGE. A: recombinant
GST-TcNaa35. B: GST-TcNaa38. C: GST-TcNaa10 and D:
GST-TcNaa15. Samples loaded in the different lanes are as
follows: Lane 1, molecular mass in kDa. Lane 2, noninduced
(NI). Lane 3, induced (IND). Lane 4, pellet (P). Lane
5, supernatant (Sup). Lane 6, semipurified (S/Purified).
Supplementary Figure 3: localization of TcNaa38 and
TcNaa15. Numbers 1 to 5 denote midlog epimastigotes,
stationary epimastigotes, metacyclic trypomastigotes,
trypomastigotes, and amastigotes, respectively. T. cruzi four
developmental stages were immunolabelled with A, anti-
TcNaa38 and B, anti-TcNaa15. The nucleus and kinetoplast
were visualized using DAPI stain (N+K), scale bars = 5
𝜇m. Supplementary Figure 4: localization of TcNaa30 and
TcNaa38 in internal amastigotes. Parasites were allowed to
invade Vero cells and divide. Cells were immunolabelled with
anti-TcNaa30 and anti-TcNaa38 (green) and counter labeled
with DAPI (blue) to visualize the nucleus and kinetoplast,
scale bars = 10 𝜇M. Supplementary Figure 5: phenotype
of the knock down of putative T. brucei Naa30 by RNAi
showing growth curves and mRNA level; A, wild type;
B, transfected; C, the parasite growth of the transfectants
compared to that of the wild type (blue). Cells at a density
of 2.5x104/ml were grown in the absence (- Tet) or presence
(+Tet) of tetracycline (100ng/ml) over a period of 72 h. The
result is a representative of the mean parasite growth of T. b.
brucei 427 obtained from three independent experiments. D,
gene expression analysis of wild type (W), noninduced ( -),
and induced ( +) cells using Reverse Transcriptase PCR. The
products were separated on a 2 % agarose gel alongside a 1kb
DNA ladder and visualized using ethidium bromide staining.
Shown is days 0-48 h and day 72 h post-RNAi induction.
Actin (700bp) was amplified as an internal control alongside
NatC catalytic subunit (573bp). The cell densities used for
days 0, 24, 48, and 72 h from which RNA was isolated
were 1x105/ml, 2.73x105/ml, 3.75x105/ml, and 4.7x105/ml,
respectively. (Supplementary Materials)
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